Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
Daniel Nava Rodrigues(Institute of Cancer Research), Charles G. Drake(Columbia University Irving Medical Center), George Seed(Institute of Cancer Research), Larissa Mendes(Royal Marsden Hospital), Pasquale Rescigno(Institute of Cancer Research), Michael T. Schweizer(Fred Hutch Cancer Center), Gunther Boysen, Joshua Armenia(AstraZeneca (United Kingdom)), Mary‐Ellen Taplin(University of Massachusetts Chan Medical School), Stephen J. Salipante(University of Washington), Diana Miao(Broad Institute), David Dolling(Institute of Cancer Research), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Charles L. Sawyers(Memorial Sloan Kettering Cancer Center), Mark A. Rubin(University of Bern), Joaquı́n Mateo(Royal Marsden NHS Foundation Trust), Mateus Crespo(Institute of Cancer Research), Alan D. D’Andrea(Dana-Farber Cancer Institute), Himisha Beltran(Dana-Farber Cancer Institute), Marcin Cieślik(University of Michigan), Kelly P. Burke(Harvard University), Claire A. Margolis(Broad Institute), Wassim Abida(Memorial Sloan Kettering Cancer Center), Susana Miranda(Royal Marsden NHS Foundation Trust), Colin C. Pritchard(Animal and Plant Health Agency), Matthew Clarke(University of Aberdeen), Peter S. Nelson(Fred Hutch Cancer Center), Adam Sharp(Institute of Cancer Research), Howard I. Scher(Memorial Sloan Kettering Cancer Center), Kent W. Mouw(Massachusetts General Hospital), Ana Ferreira(Institute of Cancer Research), Dan R. Robinson(University of Michigan), Zafeiris Zafeiriou(Royal Marsden NHS Foundation Trust), Daniel Keliher(Broad Institute), Andrea Alimonti(Veneto Institute of Molecular Medicine), Suzanne Carreira(Institute of Cancer Research), Christopher J. Lord(Institute of Cancer Research), Diletta Bianchini(Royal Marsden NHS Foundation Trust), Saud H. AlDubayan(Broad Institute), David Liu(University of Louisville), Ruth Riisnaes(Institute of Cancer Research), Ines Figueiredo(Institute of Cancer Research), Stephanie A. Mullane(Broad Institute), Mariane Fontes(Royal Marsden NHS Foundation Trust), Arul M. Chinnaiyan(Howard Hughes Medical Institute), Elizabeth Heath(Baruch College), Cláudia Bertan(Institute of Cancer Research), Maryou Lambros(Institute of Cancer Research), Semini Sumanasuriya(Institute of Cancer Research)
Cited by 53
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k